Comparison of Delta-Shaped and Billroth II After TLDG
Launched by THE FIRST HOSPITAL OF JILIN UNIVERSITY · Feb 21, 2015
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Methods: 78 consecutive patients who underwent TLDG in First Hospital of Jilin University between October 2012 and December 2014 were enrolled in this study . All patients were divided randomly into two groups:Delta-shaped anastomosis group (DS group) and Billroth II anastomosis group (B-II group), and the patients in DS group underwent Delta-shaped anastomosis after TLDG, and the patients in B-II group underwent Billroth-II anastomosis after TLDG.Outcome measures,resected margin,operative time,anastomosis time,number of stapler cartridges used,length of the incision,the time of first flatu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • carcinoma located in the lower 1/3 of gastric body or antrum of stomach
- • diagnosed by endoscopy ,endoscopic ultrasonography and abdominal CT scan
- • diameter of the tumor \<3cm
- • no pyloric obstruction
- Exclusion Criteria:
- • diameter of the tumor ≥3cm
- • associated with obstruction, bleeding, emergency surgery or surgical intervention
- • tumor with extensive metastasis
- • patient had previously undergone gastrostomy
About The First Hospital Of Jilin University
The First Hospital of Jilin University is a prestigious academic medical center located in Changchun, China, dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a leading institution in medical education and research, the hospital actively engages in a wide range of clinical trials aimed at improving treatment outcomes and enhancing patient safety across various specialties. With a commitment to excellence, the First Hospital collaborates with multidisciplinary teams of healthcare professionals, leveraging cutting-edge technologies and methodologies to contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Quan Wang, Doctor
Study Director
The First Hospital of Jilin University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials